Diagnostic Value of Interleukin-33 in Neonatal Sepsis

Document Type : Original Article

Authors

1 Pediatrics department, Faculty of Medicine, Beni-Suef University

2 Clinical and chemical Pathology department, Faculty of Medicine, Beni-Suef University

Abstract

Background: Most infant deaths are attributed to neonatal sepsis. Reduced morbidity and mortality can be achieved with prompt diagnosis. Due to the disease's rapid course, accurate utilization of disease-specific biomarkers is crucial for timely diagnosis and treatment. Aim and objective: This study aimed to find out serum IL33 levels in neonates with sepsis and to investigate its role in the identifying of neonatal sepsis. Methods: Case-control research was performed on 45 cases diagnosed with neonatal sepsis with positive blood cultures and 45 healthy neonates as controls. A peripheral blood sample was taken from the patients and controls then IL33 levels were measured by ELISA. Results: In newborn sepsis individuals, serum IL 33 levels were significantly greater than in healthy controls (203.9±63.1vs.127.4±30.5 ng/ml, respectively: p less than 0.001). Serum IL33 levels were significantly positively correlated with CRP levels in neonatal sepsis patients. IL33 is increased in survivor than in non-survivor cases. Conclusion: Elevated levels of interleukin 33 strongly correlate with neonatal sepsis so it might function as a reliable a diagnostic indicator for neonatal sepsis.

Keywords

Main Subjects

References

  1. Shane AI, Sanchez PJ & Stoll BJ. Neonatal sepsis. Lancet, 2017; 390:1770-80.
  2. Liang LD, Kotadia N, English L, Kissoon N, Ansermino JM, Kabakyenga J, et al. Predictors of mortality in neonates and infants hospitalized with sepsis or serious infections in developing countries: a systematic review. Front pediatr, 2018; 6:277.
  3. Mersha A, Worku T, Shibiru S, Bante A, Molla A. Neonatal sepsis and associated factors among newborns in hospitals of Wolaita Sodo Town, Southern Ethiopia. Research and Reports in Neonatology, 2019; 9:1.
  4. Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of pediatric and neonatal sepsis: a systematic review. Lancet Respir Med., 2018; 6:223–30.
  5. Rao L, Song Z, Yu X, Tu Q, He Y, Luo Y, Yin Y Chen D. Progranulin as a novel biomarker in diagnosis of early-onset neonatal sepsis. Cytokine. 2020 Apr 1; 128:155000.
  6. Machado JR, Soave DF, da Silva MV. Neonatal sepsis and inflammatory mediators. Mediators Inflamm. 2014; 4:269681.
  7. Halil H, Tayman C, Buyuktiryaki M, Okur N, Cakır U, Serkant U. Serum Interleukin-33 as a Biomarker in Predicting Neonatal Sepsis in Premature Infants. Combinatorial Chemistry & High Throughput Screening, 2018; 21(7), 510-515.
  8. Stocker M, Van Herk W, El Helou S, Dutta S, Fontana MS, et al., Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). The Lancet. 2017 Aug 26; 390(10097):871-81.
  9. Zhu JF, Xu Y, Zhao J, Li X, Meng X, Wang TQ. IL-33 protects mice against DSS-induced chronic colitis by increasing both regulatory B cell and regulatory T cell responses as well as decreasing Th17 cell response. J Immunol Res. 2018:1827901.
  10. Shehab El-Din EM, El-Sokkary MM, Bassiouny MR, Hassan R. Epidemiology of Neonatal Sepsis and. Implicated Pathogens: A Study from Egypt. BioMed Research International, 2015; 1-11. 11.
  11. Awad HA, Mohamed MH, Badran NF, Mohsen M, Abd-Elrhman AS. Multidrug-resistant organisms in neonatal sepsis in two tertiary neonatal ICUs, Egypt. Journal of the Egyptian Public Health Association, 2016; 91(1):31-8.
  12. Aydemir C, Aydemir H, Kokturk F, Kulah C, Mungan AG. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis. BMC Pediatr. 2018; 18(1):253.
  13. Paul D, IbneSattar A, Roy C. Role of neutrophil CD64 as an emerging biomarker in the evaluation of neonatal sepsis. Int Clin Pathol J. 2017; 4(5):114–118.
  14. Ebrahem AM, Jameel SK, Abbas AH. Estimation Of Interleukin 27 And Interleukin 33 Serum Levels In Iraqi Neonatal Sepsis. Journal of Pharmaceutical Negative Results. 2022; 10: 136-41.
  15. Noha FN, Doya LJ, Jouni O Perinatal Risk Factors and Early Onset of Neonatal Sepsis. Int J Pediatr Res, 2022; 8: 088.
  16. Abdellatif M, Al-Khabori, Rahman AU, Khan AA, Al-Farsi A, Ali K. Outcome of Late-onset Neonatal Sepsis at a Tertiary Hospital in Oman. Oman medical journal, 2019; 34(4), 302–307.
  17. Jemal M, Tinshku F, Nigussie Y, Kefyalew B, Alemu C. Trend Analysis of MultidrugResistant Bacterial Pathogens Causing Neonatal Sepsis at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: A Retrospective Study. International journal of microbiology, 2021; 9992994.
  18. Abood RM. Laboratory assessment of C-reactive protein (CRP), procalcitonin (PCT) and serum amyloid A-2 protein(SAA2) as biomarkers of pediatric bacterial bloodstream infection, Master thesis, College of Medicine in Mustansiriya University, 2021.
  19. Yang A, Liu J, Yue L, Wang H, Yang W, Yang G. Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis. Clinical chemistry and laboratory medicine, 2016; 54(2), 345–351.
  20. Nascimento DC, Melo PH, Piñeros AR, Ferreira RG, Colón DF. IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. Nat Commun. 2017; 8:14919.

Files

Share

How to cite

Statistics